IUI1 Stock Overview
Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for IUI1 from our risk checks.
Intuitive Surgical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$524.00 |
| 52 Week High | US$524.00 |
| 52 Week Low | US$281.80 |
| Beta | 1.39 |
| 11 Month Change | 9.74% |
| 3 Month Change | 18.20% |
| 1 Year Change | 78.99% |
| 33 Year Change | 71.47% |
| 5 Year Change | n/a |
| Change since IPO | 11,467.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| IUI1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.9% | -2.5% | -1.3% |
| 1Y | 79.0% | -8.4% | 7.4% |
Return vs Industry: IUI1 exceeded the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: IUI1 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| IUI1 volatility | |
|---|---|
| IUI1 Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IUI1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: IUI1's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 13,676 | Gary Guthart | www.intuitive.com |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
Intuitive Surgical, Inc. Fundamentals Summary
| IUI1 fundamental statistics | |
|---|---|
| Market cap | €184.11b |
| Earnings (TTM) | €2.14b |
| Revenue (TTM) | €7.51b |
87.4x
P/E Ratio24.9x
P/S RatioIs IUI1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IUI1 income statement (TTM) | |
|---|---|
| Revenue | US$7.87b |
| Cost of Revenue | US$2.60b |
| Gross Profit | US$5.27b |
| Other Expenses | US$3.03b |
| Earnings | US$2.24b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.30 |
| Gross Margin | 66.98% |
| Net Profit Margin | 28.51% |
| Debt/Equity Ratio | 0% |
How did IUI1 perform over the long term?
See historical performance and comparison